# Enhancement of Motor Function with Reboxetine and Transcranial Direct Current Stimulation

> **NCT00853866** · PHASE4 · COMPLETED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 12 (actual)

## Conditions studied

- Cerebral Stroke

## Interventions

- **DRUG:** reboxetine
- **DRUG:** Placebo
- **DEVICE:** tDCS verum
- **DEVICE:** tDCS sham

## Key facts

- **NCT ID:** NCT00853866
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-11
- **Final completion:** 2010-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-12-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00853866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00853866, "Enhancement of Motor Function with Reboxetine and Transcranial Direct Current Stimulation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00853866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*